OFLOXACINE – NIKAPHARM

Broad-spectrum antimicrobial agent from the group of fluoroquinolones, acts on a bacterial enzyme DNA gyrase, providing super-convolution and thus the stability of bacterial DNA (destabilization of DNA chains leads to their death). Has a bactericidal effect. Active against microorganisms producing beta-lactamase and fast-growing atypical microbacteria.

Infectious-inflammatory diseases caused by sensitive microorganisms:
- Infection of the respiratory system (bronchitis, pneumonia);
- Infection of ENT organs (sinusitis, pharyngitis, otitis media, laryngitis, tracheitis);
- Infections of the skin, soft tissues;
- Infection of bones, joints;
- Infectious-inflammatory diseases of the abdominal cavity and bile ducts;
- Infection of the kidneys (pyelonephritis), urinary tract (cystitis, urethritis);
- Infections of the pelvic organs (endometritis, salpingitis, oophoritis, cervicitis, parametritis, prostatitis);
- infections of the genital organs (colpitis, orchitis, epididymitis);
- Gonorrhea;
- Chlamydia;
Prevention of infections in patients with impaired immune status (including neutropenia).